trending Market Intelligence /marketintelligence/en/news-insights/trending/TNx2wf3S53o3RTXg_aLBoA2 content esgSubNav
In This List

NeoGenomics names chief scientific officer

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise

Blog

Insight Weekly: US companies boost liquidity; auto insurers hike rates; office sector risk rises


NeoGenomics names chief scientific officer

NeoGenomics Inc. said it appointed Lawrence Weiss as the company's chief scientific officer.

Weiss has served as medical director and laboratory director for NeoGenomics Laboratories Inc. since joining NeoGenomics as part of the Clarient Diagnostic Services Inc. acquisition in 2015.

Previously, he acted as laboratory director for Clarient Diagnostic and chairman of the department of pathology and director of laboratories for City of Hope National Medical Center.

Fort Myers, Fla.-based NeoGenomics operates a network of cancer-focused genetic testing laboratories.